TABLE 1.
Parameter | Category | Value |
---|---|---|
Age | Mean (SD) | 46.2 (10.8) |
Range | 10–81 | |
Sex [no. (%)] | Males | 478 (54.4) |
Females | 400 (45.6) | |
Race [no. (%)] | Caucasian | 630 (71.8) |
Black | 117 (13.3) | |
Hispanic | 93 (10.6) | |
Asian | 18 (2.0) | |
Native-American | 2 (0.2) | |
Unknown | 8 (0.9) | |
Other | 10 (1.1) | |
ALT level | Mean (SD) | 95.3 (79.8) |
Range | 7–668 | |
Reason for visit [no. (%)] | Prior HCV diagnosis | 346 (39.4) |
HCV evaluation | 302 (34.4) | |
Liver disease evaluation | 237 (27.0) | |
Prior HCV therapy [no. (%)] | Yes | 160 (18.2) |
No | 718 (81.8) | |
Clinical diagnosis [no. (%)] | Chronic HCV infection | 636 (72.4) |
Autoimmune hepatitis | 20 (2.3) | |
Alcoholic liver disease | 49 (5.6) | |
Chronic HBV infection | 37 (4.2) | |
Primary biliary cirrhosis | 45 (5.1) | |
Cryptogenic cirrhosis | 18 (2.0) | |
Chronic renal failure | 3 (0.3) | |
Other | 106 (12.1) | |
Liver biopsy performed [no. (%)] | Yes | 515 (58.6) |
No | 363 (41.4) |